The Trump administration has been talking tough on drug prices for many months and, of course, pharmaceutical companies and other organizations have pushed back because they mostly oppose controls on the free market for prescription drugs.
For health care journalists covering these proposals, it’s essential to remain skeptical of any group that offers support or opposition and, as always, follow the money. Continue reading
Image by SalFlako via Flickr
Think the only big lawsuit pending on the Affordable Care Act is the Texas fight over whether the whole law is unconstitutional? Think again.
Several lawsuits are still working their way through the courts involving the unpaid cost-sharing reduction (CSR) subsidies, and risk corridor payments. Potentially, the Trump administration could be forced to pay insurers billions of dollars. (Paul Demko has reported on this extensively for Politico, and this post cribs shamelessly — but gratefully — from his knowledge.) Continue reading
Photo: BBC World Service via Flickr
President Trump, along with immigration opponents, repeatedly assert that immigrants are bringing infectious diseases to the U.S., but never provide any data to back up their claims.
That is because virtually every public health expert says there isn’t any evidence that this is the case. Continue reading
The Action for Dental Health Act of 2018 has been described as a modest piece of legislation.
But supporters have also hailed the measure as a heartening acknowledgment by federal legislators of the need to respond to the long-unmet dental needs of millions of Americans. In a rare show of bipartisanship, Congress last week passed the legislation, which is headed to President Trump’s desk to be signed into law. Continue reading
Photo: Turtle Mint via Flickr
The 2019 ACA enrollment season is getting off to a stronger start – more health plan participation in the federal exchange, lower premiums – than many had expected.
It still faces enormous stresses, with the elimination of the mandate penalty, and the availability of alternative health coverage options that may undermine the markets. But for now, the news is quite good. Continue reading
